RESELECT trial to test treatments for rescuing bone marrow function

A clinical trial of new treatments for relapsed acquired aplastic anaemia or Bone Marrow Failure Syndrome (BMFS) in younger Australians is to go ahead with $1 million in funding from the Medical Research Future Fund (MRFF). Funding for the RESELECT trial will be provided to Maddie Riewoldt’s Vision, which operates the Centre of Research Excellence in ...

Already a member?

Login to keep reading.

© 2020 the limbic